BTA needs to win every battle, no matter how large or small, just to keep favour with investors, which is why this is a disappointing result... regardless of materiality of prevention indications.
Does this mean another 2 year trial?
BTA Price at posting:
92.5¢ Sentiment: Buy Disclosure: Held